Eupraxia Pharmaceuticals ... (EPRX)
NASDAQ: EPRX
· Real-Time Price · USD
5.32
0.04 (0.76%)
At close: Aug 15, 2025, 3:49 PM
5.30
-0.43%
After-hours: Aug 15, 2025, 04:55 PM EDT
Eupraxia Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | 2.98M | 2.98M | 2.98M | 2.98M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 57.51K | 107.97K | 1.6M | 1.65M | 1.64M | 1.64M | 202.83K | 202.81K | 202.53K | 193.27K | 179.56K | 159.24K | 130.66K | 111.53K | 70.12K | 40.55K | 20.24K |
Gross Profit | -57.51K | -107.97K | 1.38M | 1.33M | 1.34M | 1.34M | -202.83K | -202.81K | -202.53K | -193.27K | -179.56K | -159.24K | -130.66K | -111.53K | -70.12K | -40.55K | -20.24K |
Operating Income | -27.43M | -29.34M | -28.2M | -30.55M | -31.44M | -27.27M | -29.49M | -25.54M | -24.13M | -22.63M | -17.47M | -17.84M | -17.1M | -20.87M | -17.52M | -13.09M | -8.48M |
Interest Income | 1.23M | 1.16M | 1.12M | 1.01M | 760.27K | 686.94K | 678.57K | 625.51K | 561.82K | 427.06K | 282.59K | 156.78K | 80.08K | 51.88K | 27.07K | 12.14K | 373.00 |
Pretax Income | -28.59M | -30.12M | -26.91M | -27.46M | -27.16M | -23.91M | -28.67M | -26.92M | -25.2M | -23.92M | -18.61M | -18.95M | -18.27M | -23.37M | -19.73M | -15.66M | -11.05M |
Net Income | -26.22M | -27.61M | -24.2M | -24.57M | -26.39M | -23.2M | -27.92M | -26.27M | -24.53M | -23.26M | -18.15M | -18.47M | -17.82M | -22.99M | -19.41M | -15.49M | -11.04M |
Selling & General & Admin | 11.68M | 11.78M | 7.98M | 8.35M | 8.61M | 6.5M | 8.95M | 7.32M | 5.66M | 5.81M | 5.13M | 5.64M | 5.79M | 8.89M | 7.55M | 6.37M | 5.3M |
Research & Development | 15.75M | 17.5M | 20.49M | 22.54M | 23.25M | 20.62M | 20.24M | 18M | 18.23M | 17.2M | 12.54M | 12.24M | 10.95M | 9.68M | 7.64M | 4.37M | 1.14M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 27.43M | 29.29M | 28.33M | 30.94M | 32.04M | 27.86M | 30.13M | 26.12M | 24.61M | 23.2M | 17.84M | 18.04M | 16.87M | 18.68M | 15.28M | 10.82M | 6.52M |
Interest Expense | 282.43K | 603.57K | 859.23K | 1.18M | 1.2M | 1.17M | 1.26M | 1.19M | 1.18M | 1.15M | 1.07M | 1.07M | 934.69K | 1.02M | 1.19M | 1.23M | 1.59M |
Selling & Marketing Expenses | n/a | 859.81K | 859.81K | 859.81K | 859.81K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 27.43M | 29.34M | 28.38M | 30.99M | 32.09M | 27.91M | 30.18M | 26.17M | 24.66M | 23.2M | 17.84M | 18.04M | 16.87M | 18.68M | 15.28M | 10.82M | 6.52M |
Income Tax Expense | -402 | 3.55K | -289.71K | -289.71K | 104.97K | 15.88K | 307.33K | 307.33K | -82.34K | n/a | n/a | n/a | n/a | -1.49M | -1.08M | -685.53K | -190.87K |
Shares Outstanding (Basic) | 35.69M | 35.62M | 35.62M | 35.62M | 28.81M | 27.31M | 25.52M | 22.01M | 21.7M | 21.59M | 21.39M | 19.9M | 14.24M | 12.41M | 14.24M | 13.23M | 13.05M |
Shares Outstanding (Diluted) | 35.69M | 35.62M | 35.62M | 35.62M | 28.81M | 27.31M | 25.52M | 22.01M | 21.7M | 21.59M | 21.39M | 19.9M | 14.24M | 12.41M | 14.24M | 13.23M | 13.05M |
EPS (Basic) | -0.76 | -0.83 | -0.77 | -0.85 | -1.04 | -0.99 | -1.25 | -1.22 | -1.17 | -1.2 | -1.09 | -1.22 | -1.32 | -1.74 | -1.45 | -1.18 | -0.85 |
EPS (Diluted) | -0.76 | -0.83 | -0.77 | -0.85 | -1.04 | -0.99 | -1.25 | -1.22 | -1.17 | -1.2 | -1.09 | -1.22 | -1.32 | -1.74 | -1.45 | -1.18 | -0.85 |
EBITDA | -25.89M | -28.15M | -31.19M | -31.3M | -32.96M | -28.78M | -26.78M | -25.34M | -23.92M | -22.44M | -16.57M | -16.95M | -16.24M | -20.04M | -17.08M | -12.65M | -7.72M |
EBIT | -26.07M | -27.17M | -30.21M | -28.71M | -32.13M | -28.8M | -24.67M | -23.86M | -19.24M | -17.45M | -13.73M | -13.81M | -13.58M | -17.5M | -14.66M | -11.14M | -7.13M |
Depreciation & Amortization | 180.79K | 184.76K | 138.07K | 150.22K | 157.37K | 155.53K | 202.83K | 202.81K | 202.53K | 193.27K | 179.56K | 159.24K | 130.66K | 111.53K | 92.3K | 83.69K | 85.1K |